Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Choose injectable GLP-1s if: Maximum weight loss is your primary goal You want proven, consistent results backed by extensive clinical trials Weekly dosing fits better into your routine than daily medication You have absorption issues or take other morning medications Cost is a concern (compounded injectables are most affordable) You value the gold standard with predictable outcomes Consider FDA-approved oral tablets if: You're extremely needle-averse and won't use injections You have modest weight loss goals You can maintain a strict morning medication routine with 30-minute fasting You prefer FDA-approved medications over compounded options You don't mind the lower bioavailability and the need for higher doses Consider compounded ODT formulations if: You're needle-averse but want to avoid swallowing pills You're willing to try an emerging option without clinical validation You can afford the higher cost compared to compounded injectables You're comfortable with daily dosing For most people seeking significant weight loss, injectable GLP-1 medications currently offer superior results, better convenience (despite being injections), and more cost-effective options through oral options
Very low calorie diets periodically, meal replacement programs, or intermittent fasting approaches may help some individuals maintain weight loss after tirzepatide discontinuation
Hierarchy of Evidence: Level D (In vitro and rodent models)
If needed, the dosage can be increased to 10 mg once weekly in weeks 13- 16, 12.5 in weeks 17-20, and 15 mg in weeks 21-24
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
Your doses will be smaller than intended unless you recalculate
